当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3712297
自主品牌
已选条件
-
T2601Vidofludimus4sc-101；SC12267
Vidofludimus (4SC-101, SC12267) is a novel small molecule inhibitor of dihydroorotate dehydrogenase (DHODH).
价 格：￥电议型 号：T2601产 地：中国大陆
-
T2601VidofludimusVidofludimus,SC12267,4sc-101
Vidofludimus (4SC-101, SC12267) is a novel small molecule inhibitor of dihydroorotate dehydrogenase (DHODH).
价 格：￥电议型 号：T2601产 地：美洲
-
T70899Vidofludimus hemicalcium；化合物 Vidofludimus calcium4sc-101 hemicalcium|||SC12267 hemicalcium|||4sc-101
Vidofludimus hemicalcium (4sc-101; SC12267) is an orally active compound that acts as a dihydroorotate dehydrogenase (DHODH) inhibitor and serves as a novel modulator of the farnesoid X receptor (FXR). This immunomodulatory agent is utilized in the research of autoimmune disorders, including inflammatory bowel disease (IBD), and is explored for its potential in fatty liver disease research through FXR targeting.
价 格：￥电议型 号：T70899产 地：中国大陆
-
T2601Vidofludimus；化合物VidofludimusSC12267|||4sc-101；SC12267|||4sc-101
Vidofludimus (SC12267) (4SC-101, SC12267) is a novel small molecule inhibitor of dihydroorotate dehydrogenase (DHODH).
价 格：￥电议型 号：T2601产 地：中国大陆
